Emami advanced 1.37% to Rs 496.50 after the company said that its board will meet on 3 February 2022 to consider a proposal for the buyback of the equity shares of the company.
On the same day, the board will also consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2021 along with a proposal for declaration of a second interim equity dividend for the financial year 2021-22.
The company recorded 56% growth in consolidated net profit to Rs 185 crore on a 7% rise in net sales to Rs 789 crore in Q2 FY22 over Q2 FY21.
Emami is one of India's leading FMCG companies engaged in manufacturing & marketing of personal care & healthcare products.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app